Absci Corp (ABSI)
5.08
+0.10
(+2.01%)
USD |
NASDAQ |
May 03, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Absci Cash from Investing (TTM): 81.94M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 81.94M |
September 30, 2023 | 32.81M |
June 30, 2023 | -66.05M |
March 31, 2023 | -147.43M |
December 31, 2022 | -126.98M |
September 30, 2022 | -105.12M |
June 30, 2022 | -33.22M |
Date | Value |
---|---|
March 31, 2022 | -65.36M |
December 31, 2021 | -67.38M |
September 30, 2021 | -59.97M |
June 30, 2021 | -53.89M |
March 31, 2021 | -10.86M |
December 31, 2020 | -2.171M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-147.43M
Minimum
Mar 2023
81.94M
Maximum
Dec 2023
-47.97M
Average
-59.97M
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
Amgen Inc | -27.78B |
Creative Medical Technology Holdings Inc | 3.445M |
CytomX Therapeutics Inc | -150.67M |
HOOKIPA Pharma Inc | -4.159M |
Recursion Pharmaceuticals Inc | -10.23M |